NO180773C - Fremgangsmåte for fremstilling av et farmasöytisk preparat inneholdende en kombinasjon av angiotensin-omvandlende-enzymhemmer med kaliumkanal-modulator - Google Patents

Fremgangsmåte for fremstilling av et farmasöytisk preparat inneholdende en kombinasjon av angiotensin-omvandlende-enzymhemmer med kaliumkanal-modulator

Info

Publication number
NO180773C
NO180773C NO892125A NO892125A NO180773C NO 180773 C NO180773 C NO 180773C NO 892125 A NO892125 A NO 892125A NO 892125 A NO892125 A NO 892125A NO 180773 C NO180773 C NO 180773C
Authority
NO
Norway
Prior art keywords
preparation
angiotensin
converting enzyme
potassium channel
combination
Prior art date
Application number
NO892125A
Other languages
English (en)
Norwegian (no)
Other versions
NO180773B (no
NO892125D0 (no
NO892125L (no
Inventor
Reinhard Becker
Rainer Henning
Hansjoerg Urbach
Volker Teetz
Heinrich Christian Englert
Dieter Mania
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO892125D0 publication Critical patent/NO892125D0/no
Publication of NO892125L publication Critical patent/NO892125L/no
Publication of NO180773B publication Critical patent/NO180773B/no
Publication of NO180773C publication Critical patent/NO180773C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • H—ELECTRICITY
    • H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
    • H02K—DYNAMO-ELECTRIC MACHINES
    • H02K29/00—Motors or generators having non-mechanical commutating devices, e.g. discharge tubes or semiconductor devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Power Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
NO892125A 1988-05-28 1989-05-26 Fremgangsmåte for fremstilling av et farmasöytisk preparat inneholdende en kombinasjon av angiotensin-omvandlende-enzymhemmer med kaliumkanal-modulator NO180773C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3818245A DE3818245A1 (de) 1988-05-28 1988-05-28 Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln

Publications (4)

Publication Number Publication Date
NO892125D0 NO892125D0 (no) 1989-05-26
NO892125L NO892125L (no) 1989-11-29
NO180773B NO180773B (no) 1997-03-10
NO180773C true NO180773C (no) 1997-06-18

Family

ID=6355378

Family Applications (1)

Application Number Title Priority Date Filing Date
NO892125A NO180773C (no) 1988-05-28 1989-05-26 Fremgangsmåte for fremstilling av et farmasöytisk preparat inneholdende en kombinasjon av angiotensin-omvandlende-enzymhemmer med kaliumkanal-modulator

Country Status (18)

Country Link
US (1) US4975453A (da)
EP (1) EP0344572B1 (da)
JP (1) JPH0219326A (da)
KR (1) KR900018139A (da)
AT (1) ATE98130T1 (da)
AU (1) AU623397B2 (da)
CA (1) CA1332350C (da)
DE (2) DE3818245A1 (da)
DK (1) DK258889A (da)
ES (1) ES2061787T3 (da)
HU (1) HU205714B (da)
IE (1) IE63328B1 (da)
IL (1) IL90414A (da)
NO (1) NO180773C (da)
NZ (1) NZ229311A (da)
PH (1) PH26420A (da)
PT (1) PT90661B (da)
ZA (1) ZA894013B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2684553B1 (fr) * 1991-12-10 1995-04-07 Bioprojet Soc Civ Nouveaux medicaments pour le traitement de l'hypertension arterielle, de l'insuffisance cardiaque chronique, de l'insuffisance renale et, de maniere generale, d'affections entrainant une retention hydrosodee.
TW244350B (da) * 1991-12-14 1995-04-01 Hoechst Ag
US6083986A (en) * 1996-07-26 2000-07-04 Icagen, Inc. Potassium channel inhibitors
US6333337B1 (en) 1998-01-27 2001-12-25 Icagen, Inc. Potassium channel inhibitors
SE9903028D0 (sv) * 1999-08-27 1999-08-27 Astra Ab New use
DE60022525T2 (de) * 1999-08-30 2006-06-14 Sanofi Aventis Deutschland Ramipril zur vorbeugung von kardiovaskulären vorfällen
US6458794B2 (en) 1999-12-21 2002-10-01 Icagen, Inc. Potassium channel inhibitors
US6566380B2 (en) * 2000-07-25 2003-05-20 Icagen, Inc. Potassium channel inhibitors
US6620849B2 (en) 2000-07-26 2003-09-16 Icafen, Inc. Potassium channel inhibitors
US6849634B2 (en) 2000-12-21 2005-02-01 Icagen Potassium channel inhibitors
KR100591857B1 (ko) * 2004-06-04 2006-06-23 한국유나이티드제약 주식회사 안정성이 개선된 라미프릴 함유 약제학적 조성물
JP2008519063A (ja) * 2004-11-05 2008-06-05 キング・ファーマシューティカルズ・リサーチ・アンド・デベロプメント・インコーポレイティッド 安定化ラミプリル組成物及びその製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3274350D1 (en) * 1981-09-25 1987-01-08 Beecham Group Plc Pharmaceutically active benzopyran compounds
EP0107423B1 (en) * 1982-10-19 1986-07-23 Beecham Group Plc Novel chromans and chromenes
GB8308064D0 (en) * 1983-03-24 1983-05-05 Beecham Group Plc Active compounds
GB8308062D0 (en) * 1983-03-24 1983-05-05 Beecham Group Plc Active compounds
DE3410732A1 (de) * 1984-03-23 1985-09-26 Hoechst Ag, 6230 Frankfurt Methode zur behandlung des glaukoms
DE3437917A1 (de) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
DE3536687A1 (de) * 1985-10-15 1987-04-16 Hoechst Ag Verfahren zur behandlung von atherosklerose, thrombose und der peripheren gefaesskrankheit
DE3627613A1 (de) * 1986-08-14 1988-02-18 Merck Patent Gmbh Pharmazeutische zubereitung
DE3629060A1 (de) * 1986-08-27 1988-03-03 Bayer Ag Kombination von positiv inotrop wirkenden dihydropyridinen mit ace-hemmern, sowie ihre verwendung in arzneimitteln
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
HU199681B (en) * 1986-11-03 1990-03-28 Sandoz Ag Process for producing new pharmaceutical composition against hypertension and atonic cardiac decomposition
ES2055709T3 (es) * 1986-12-06 1994-09-01 Beecham Group Plc Un procedimiento para preparar una composicion farmaceutica.

Also Published As

Publication number Publication date
IE891770L (en) 1989-11-28
DK258889A (da) 1989-11-29
DE58906338D1 (de) 1994-01-20
NZ229311A (en) 1992-05-26
PH26420A (en) 1992-07-15
DE3818245A1 (de) 1989-12-07
NO180773B (no) 1997-03-10
PT90661A (pt) 1989-11-30
IL90414A (en) 1993-07-08
HUT52370A (en) 1990-07-28
NO892125D0 (no) 1989-05-26
EP0344572B1 (de) 1993-12-08
CA1332350C (en) 1994-10-11
AU623397B2 (en) 1992-05-14
DK258889D0 (da) 1989-05-26
IL90414A0 (en) 1990-01-18
AU3522089A (en) 1989-11-30
HU205714B (en) 1992-06-29
KR900018139A (ko) 1990-12-20
NO892125L (no) 1989-11-29
ATE98130T1 (de) 1993-12-15
ZA894013B (en) 1990-02-28
ES2061787T3 (es) 1994-12-16
JPH0219326A (ja) 1990-01-23
US4975453A (en) 1990-12-04
EP0344572A2 (de) 1989-12-06
IE63328B1 (en) 1995-04-19
PT90661B (pt) 1994-10-31
EP0344572A3 (de) 1991-01-16

Similar Documents

Publication Publication Date Title
NO962187L (no) Sammensetninger som inhiberer apoptose, fremgangsmåter for rensing av sammensetningene og anvendelse derav
NO180773C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat inneholdende en kombinasjon av angiotensin-omvandlende-enzymhemmer med kaliumkanal-modulator
ES2117123T3 (es) Derivados de aminocetilmercaptoacetilamida utilizados como inhibidores de la encefalinasa y del enzima de conversion de angiotensina.
ES2099056T3 (es) Cepas de lactobacillus de origen humano, sus composiciones y usos de las mismas.
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
DK0654078T3 (da) Thrombinblodfraktion til anvendelse i en medicinsk procedure
ATE209482T1 (de) Transdermal applizierbares arzneimittel mit ace- hemmern
NO944430D0 (no) 4-mercaptoacetylamino-[2Åbenzazepinon(3)-derivater, og anvendelse som enkefalinaseinhibitorer
AU2443184A (en) Benzazocinones and benzazoninones
ES8307263A1 (es) Un procedimiento para la preparacion de fosfonamidas sustituidas.
ES547931A0 (es) Procedimiento para la obtencion de un medicamento que con contiene como sustencia activa la combinacion de dihidropiridinas con inhibidores ace
DK0471756T3 (da) Saccharinderivater, der er egnede som proteolytiske enzyminhibitorer, og fremstilling deraf
DE69033970T2 (de) Huperzin a analoge verbindungen
DE68921908D1 (de) Zell-assoziierte Glucosyltransferase, Antikörper dagegen und eine diese enthaltende Zusammensetzung zur Prophylaxe von Karies.
ATE60788T1 (de) Derivat von p-aminophenol mit mucrosekretolytischer fluessiger und antipyretischer wirksamkeit, dessen verfahren zur herstellung und dessen pharmazeutische zusammensetzungen.
IL88502A0 (en) Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor and methods for the preparation thereof
HUP9801075A2 (hu) Kombinált állandó dózisú angiotenzint átalakító enzim inhibítor kalciumcsatorna-antagonista, eljárás ennek előállítására, valamint alkalmazása szív- és érrendszeri betegségek kezelésében
PT86292A (pt) Processo para a preparacao de uma composicao farmaceutica anti-hipertensora,contendo um activador de canal de potassio(por exemplo,cromacalina)e um inibidor de ace(por exemplo,enalapril)
DK427886D0 (da) Farmaceutiske praeparater indeholdende inhibitorer af angiotensin-omdannende enzyn til behandling af hoejt blodtryk
FI972620A (fi) Uusia prosesseja, joilla voidaan valmistaa enkefalinaasin ja angiotensiiniä konvertoivan entsyymin inhibiittoreiden välituotteita ja näiden välituotteita
ES2196566T3 (es) Nuevos compuestos triciclicos de aminooxiamida inhibidores de la farnesil-proteina-transferasa.